Quantifying the Impact of Signal-to-background Ratios on Surgical Discrimination of Fluorescent Lesions.
Fluorescence imaging
Image-guided surgery
Indocyanine green (ICG)
Surgical performance
Surgical robotics
Journal
Molecular imaging and biology
ISSN: 1860-2002
Titre abrégé: Mol Imaging Biol
Pays: United States
ID NLM: 101125610
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
14
02
2022
accepted:
21
04
2022
revised:
28
03
2022
pubmed:
18
6
2022
medline:
3
3
2023
entrez:
17
6
2022
Statut:
ppublish
Résumé
Surgical fluorescence guidance has gained popularity in various settings, e.g., minimally invasive robot-assisted laparoscopic surgery. In pursuit of novel receptor-targeted tracers, the field of fluorescence-guided surgery is currently moving toward increasingly lower signal intensities. This highlights the importance of understanding the impact of low fluorescence intensities on clinical decision making. This study uses kinematics to investigate the impact of signal-to-background ratios (SBR) on surgical performance. Using a custom grid exercise containing hidden fluorescent targets, a da Vinci Xi robot with Firefly fluorescence endoscope and ProGrasp and Maryland forceps instruments, we studied how the participants' (N = 16) actions were influenced by the fluorescent SBR. To monitor the surgeon's actions, the surgical instrument tip was tracked using a custom video-based tracking framework. The digitized instrument tracks were then subjected to multi-parametric kinematic analysis, allowing for the isolation of various metrics (e.g., velocity, jerkiness, tortuosity). These were incorporated in scores for dexterity (Dx), decision making (DM), overall performance (PS) and proficiency. All were related to the SBR values. Multi-parametric analysis showed that task completion time, time spent in fluorescence-imaging mode and total pathlength are metrics that are directly related to the SBR. Below SBR 1.5, these values substantially increased, and handling errors became more frequent. The difference in Dx and DM between the targets that gave SBR < 1.50 and SBR > 1.50, indicates that the latter group generally yields a 2.5-fold higher Dx value and a threefold higher DM value. As these values provide the basis for the PS score, proficiency could only be achieved at SBR > 1.55. By tracking the surgical instruments we were able to, for the first time, quantitatively and objectively assess how the instrument positioning is impacted by fluorescent SBR. Our findings suggest that in ideal situations a minimum SBR of 1.5 is required to discriminate fluorescent lesions, a substantially lower value than the SBR 2 often reported in literature.
Identifiants
pubmed: 35711014
doi: 10.1007/s11307-022-01736-y
pii: 10.1007/s11307-022-01736-y
pmc: PMC9971139
doi:
Substances chimiques
Coloring Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
180-189Informations de copyright
© 2022. The Author(s).
Références
Mol Imaging Biol. 2011 Apr;13(2):199-207
pubmed: 20617389
Br J Surg. 2021 Jan 27;108(1):5-9
pubmed: 33640921
Ulster Med J. 2012 Sep;81(3):107-13
pubmed: 23620606
Anat Sci Educ. 2023 Jan;16(1):87-98
pubmed: 34894205
J Transplant. 2018 Aug 19;2018:6703056
pubmed: 30210867
Surg Endosc. 2016 Jun;30(6):2169-78
pubmed: 26304107
Surg Endosc. 2009 Mar;23(3):590-7
pubmed: 18443870
J Nucl Med. 2017 Feb;58(2):246-251
pubmed: 27587708
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1857-67
pubmed: 27020580
Surg Endosc. 2013 May;27(5):1468-77
pubmed: 23233011
Ann Transl Med. 2020 Nov;8(21):1448
pubmed: 33313193
J Nucl Med. 2022 Aug;63(8):1162-1168
pubmed: 35027369
J Nucl Med. 2022 Jan;63(1):51-56
pubmed: 33990404
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Feb;54(2):171-5
pubmed: 21290271
World J Urol. 2020 Apr;38(4):883-896
pubmed: 31286194
J Nucl Med. 2014 Sep;55(9):1552-6
pubmed: 25024425
Gland Surg. 2016 Oct;5(5):512-521
pubmed: 27867866
Neurosurg Focus. 2021 Aug;51(2):E15
pubmed: 34333472
Ann Surg Oncol. 2016 Aug;23(8):2586-95
pubmed: 27020586
J Surg Educ. 2017 Mar - Apr;74(2):295-305
pubmed: 27789192
Int J Surg. 2016 May;29:85-94
pubmed: 26992652
Cancer. 2009 Jun 1;115(11):2491-504
pubmed: 19326450
J Neurosurg. 2018 Dec 14;131(6):1974-1984
pubmed: 30554181
J Plast Reconstr Aesthet Surg. 2017 Jun;70(6):814-827
pubmed: 28292569
Ann Surg Oncol. 2021 Jun;28(6):3266-3278
pubmed: 33095359
Surg Endosc. 2020 Jan;34(1):53-60
pubmed: 30903276
Lancet Oncol. 2019 Jul;20(7):e354-e367
pubmed: 31267970
J Nucl Med. 2020 Jun;61(6):834-841
pubmed: 31712325
Med Educ. 2021 Mar;55(3):317-327
pubmed: 32790885
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1278-87
pubmed: 26768422
Semin Pediatr Surg. 2020 Apr;29(2):150903
pubmed: 32423592
J Fluoresc. 2020 Dec;30(6):1523-1530
pubmed: 32780263
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4142-4151
pubmed: 34031721
J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):799-806
pubmed: 25796218
J Nucl Med. 2018 Nov;59(11):1757-1760
pubmed: 29777008
Chem Commun (Camb). 2014 Sep 4;50(68):9733-6
pubmed: 25019263
J Urol. 2018 Jan;199(1):296-304
pubmed: 28765067
J Surg Oncol. 2018 Aug;118(2):283-300
pubmed: 29938401
J Biomed Opt. 2018 May;23(5):1-10
pubmed: 29745131
Gynecol Oncol. 2014 Dec;135(3):606-13
pubmed: 25124160
Eur Urol. 2022 Jul;82(1):97-105
pubmed: 35339318
Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):390-400
pubmed: 26269776
World J Surg. 2013 Dec;37(12):2800-11
pubmed: 23645129
Cancers (Basel). 2021 May 28;13(11):
pubmed: 34071623
Oral Oncol. 2013 Jan;49(1):15-9
pubmed: 22939692
J Endourol. 2018 May;32(5):438-444
pubmed: 29448809
Int Urol Nephrol. 2019 May;51(5):765-771
pubmed: 30903392
Surg Endosc. 2012 Sep;26(9):2587-93
pubmed: 22476836
Eur Urol. 2014 Dec;66(6):991-8
pubmed: 25092539
Perspect Clin Res. 2010 Apr;1(2):61-3
pubmed: 21829784
Gynecol Oncol. 2012 Jan;124(1):78-82
pubmed: 21996262
Mol Imaging. 2020 Jan-Dec;19:1536012120962333
pubmed: 33125289
J Nucl Med. 2021 Sep 1;62(9):1314-1317
pubmed: 33419942
Anal Methods. 2016 Jul 14;8(28):5553-5555
pubmed: 33985288
J Nucl Med. 2019 Jun;60(6):758-763
pubmed: 30733319
J Med Syst. 2020 Jan 24;44(3):56
pubmed: 31980955
J Surg Oncol. 2015 Sep;112(3):250-6
pubmed: 25974861
Anat Sci Educ. 2020 Sep;13(5):558-567
pubmed: 31887792
Surg Endosc. 2015 Jul;29(7):2046-55
pubmed: 25303914
Surg Endosc. 2014 May;28(5):1695-702
pubmed: 24385249
J Nucl Med. 2020 Feb;61(2):234-241
pubmed: 31481575
Anat Sci Educ. 2020 May;13(3):333-342
pubmed: 31301207